Stay updated on Pembrolizumab Skin Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No clinical trial content, eligibility criteria, or outcome measures appear to be altered.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Locations section listing Georgia (Atlanta, Emory University/Winship Cancer Institute) as a study site. Removed the previous Georgia Locations heading and the HHS Vulnerability Disclosure link.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check59 days agoChange DetectedA government funding lapse notice was removed from the page text, removing the informational banner about potential delays in processing and inquiries. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedNo substantive additions or deletions were detected on the Study Details page; only minor visual/layout adjustments are observed.SummaryDifference0.5%

- Check102 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.